COVID-19 countermeasures: Evidence for an intent to harm

Alexandra Latypova, also known as Sasha, is a former Pharmaceutical R&D Executive who has owned and managed several contract research organizations. She retired from the industry but launched an independent investigation into the COVID-19 pandemic response due to concerns about irregularities, cover-up, and apparent fraud committed by the U.S. Government, Department of Defense, and Department of Health and Human Services relating to the extremely high number of deaths and injuries associated with the COVID-19 ‘vaccine’ rollout.